The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.22 | Sales 2021 | 12.35 16.8 | Capitalization | 22.37M 30.44M |
---|---|---|---|---|---|
Net income 2020 | -126M -171M | Net income 2021 | -85M -116M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 39.74M | Net Debt 2021 | 17.1M 23.27M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+42.38% | 6.28B | |
-15.86% | 4.51B | |
+6.36% | 3.35B | |
-11.28% | 3.13B | |
-3.23% | 2.47B | |
+45.24% | 1.96B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |